JP2021504446A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021504446A5 JP2021504446A5 JP2020545063A JP2020545063A JP2021504446A5 JP 2021504446 A5 JP2021504446 A5 JP 2021504446A5 JP 2020545063 A JP2020545063 A JP 2020545063A JP 2020545063 A JP2020545063 A JP 2020545063A JP 2021504446 A5 JP2021504446 A5 JP 2021504446A5
- Authority
- JP
- Japan
- Prior art keywords
- nanobiological
- composition
- composition according
- patient
- accelerator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023130072A JP7772748B2 (ja) | 2017-11-21 | 2023-08-09 | 治療用ナノ生物学的組成物による訓練免疫の促進 |
| JP2025187368A JP2026015394A (ja) | 2017-11-21 | 2025-11-06 | 治療用ナノ生物学的組成物による訓練免疫の促進 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762589054P | 2017-11-21 | 2017-11-21 | |
| US62/589,054 | 2017-11-21 | ||
| PCT/US2018/061935 WO2019103998A2 (en) | 2017-11-21 | 2018-11-20 | Promoting trained immunity with therapeutic nanobiologic compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023130072A Division JP7772748B2 (ja) | 2017-11-21 | 2023-08-09 | 治療用ナノ生物学的組成物による訓練免疫の促進 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021504446A JP2021504446A (ja) | 2021-02-15 |
| JP2021504446A5 true JP2021504446A5 (https=) | 2023-05-23 |
| JP7330994B2 JP7330994B2 (ja) | 2023-08-22 |
Family
ID=66630773
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545063A Active JP7330994B2 (ja) | 2017-11-21 | 2018-11-20 | 治療用ナノ生物学的組成物による訓練免疫の促進 |
| JP2023130072A Active JP7772748B2 (ja) | 2017-11-21 | 2023-08-09 | 治療用ナノ生物学的組成物による訓練免疫の促進 |
| JP2025187368A Pending JP2026015394A (ja) | 2017-11-21 | 2025-11-06 | 治療用ナノ生物学的組成物による訓練免疫の促進 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023130072A Active JP7772748B2 (ja) | 2017-11-21 | 2023-08-09 | 治療用ナノ生物学的組成物による訓練免疫の促進 |
| JP2025187368A Pending JP2026015394A (ja) | 2017-11-21 | 2025-11-06 | 治療用ナノ生物学的組成物による訓練免疫の促進 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US20200253884A1 (https=) |
| EP (1) | EP3713548A4 (https=) |
| JP (3) | JP7330994B2 (https=) |
| CN (1) | CN111971028A (https=) |
| AU (2) | AU2018370828B2 (https=) |
| CA (1) | CA3082830A1 (https=) |
| WO (1) | WO2019103998A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109640959B (zh) | 2016-04-29 | 2023-03-17 | 西奈山伊坎医学院 | 靶向先天免疫系统以诱导长期耐受性及解决动脉粥样硬化中的巨噬细胞累积 |
| WO2021263188A1 (en) * | 2020-06-25 | 2021-12-30 | Icahn School Of Medicine At Mount Sinai | Live cell engagement assay |
| AU2022239614A1 (en) | 2021-03-19 | 2023-10-12 | Icahn School Of Medicine At Mount Sinai | Compounds for regulating trained immunity, and their methods of use |
| IT202100014747A1 (it) * | 2021-06-07 | 2022-12-07 | Consiglio Nazionale Ricerche | Derivati sterolici come nuovi ligandi del recettore dectina-1 nel trattamento terapeutico di patologie correlate a tale recettore |
| CA3222851A1 (en) | 2021-06-22 | 2022-12-29 | Roy VAN DER MEEL | Nucleic acid containing nanoparticles |
| JP2025511149A (ja) * | 2022-03-31 | 2025-04-15 | アイカーン スクール オブ メディスン アット マウント サイナイ | 免疫調節のためのスフィンゴ脂質をロードしたナノ生物製剤 |
| CA3258109A1 (en) | 2022-06-03 | 2023-12-07 | Bio-Trip B.V. | LIPID NANOPARTICLES BASED ON MULTIPURPOSE MOLECULES FOR THE ADMINISTRATION OF NUCLEIC ACIDS |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101096386A (zh) * | 2007-06-05 | 2008-01-02 | 复旦大学 | Dectin-1与热休克蛋白Hsp60聚合物及其编码核酸和应用 |
| EP2217221B1 (en) * | 2007-10-17 | 2018-06-27 | Korea Advanced Institute of Science and Technology | Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same |
| CN105903029A (zh) * | 2007-12-12 | 2016-08-31 | 大学健康网络 | 高密度脂蛋白样肽磷脂支架（“hpps”）纳米颗粒 |
| US10525152B2 (en) * | 2009-10-09 | 2020-01-07 | Signablok, Inc. | Methods and compositions for targeted imaging |
| EP2620156B1 (en) * | 2010-08-23 | 2019-03-27 | Kang Stem Biotech Co., Ltd. | Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof |
| IL292510A (en) * | 2013-11-05 | 2022-06-01 | Cognate Bioservices Inc | Combinations of checkpoint inhibitors and therapeutics to treat cancer |
| JP2018516847A (ja) * | 2015-03-25 | 2018-06-28 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 生体高分子薬を送達するための組成物及び方法 |
| US10995140B2 (en) * | 2015-06-05 | 2021-05-04 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapy |
| US20180221289A1 (en) * | 2015-08-06 | 2018-08-09 | Autotelic Llc | Phospholipid-cholesteryl ester nanoformulations and related methods |
-
2018
- 2018-11-20 EP EP18880348.0A patent/EP3713548A4/en active Pending
- 2018-11-20 CA CA3082830A patent/CA3082830A1/en active Pending
- 2018-11-20 AU AU2018370828A patent/AU2018370828B2/en active Active
- 2018-11-20 JP JP2020545063A patent/JP7330994B2/ja active Active
- 2018-11-20 CN CN201880086231.5A patent/CN111971028A/zh active Pending
- 2018-11-20 WO PCT/US2018/061935 patent/WO2019103998A2/en not_active Ceased
-
2020
- 2020-04-30 US US16/862,564 patent/US20200253884A1/en not_active Abandoned
- 2020-04-30 US US16/862,570 patent/US20200261591A1/en not_active Abandoned
-
2022
- 2022-12-07 US US18/076,759 patent/US20230355537A1/en not_active Abandoned
-
2023
- 2023-08-09 JP JP2023130072A patent/JP7772748B2/ja active Active
-
2024
- 2024-10-25 US US18/927,572 patent/US20250268839A1/en active Pending
-
2025
- 2025-02-21 AU AU2025201252A patent/AU2025201252A1/en active Pending
- 2025-11-06 JP JP2025187368A patent/JP2026015394A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021504446A5 (https=) | ||
| Kim et al. | Quantitative imaging of tumor-associated macrophages and their response to therapy using 64Cu-labeled macrin | |
| Sun et al. | Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer | |
| JP4868698B2 (ja) | マクロファージが仲介する疾患の治療および診断 | |
| CN104884065B (zh) | 治疗癌症的方法 | |
| US11357724B2 (en) | Pharmaceutical composition, preparation and uses thereof | |
| JP2015523355A5 (https=) | ||
| EP2860193A1 (en) | Polypeptide with function of synergistic targeted diagnosis and therapy of nasopharyngeal carcinoma, nanoparticles carrying same and use thereof | |
| KR102401023B1 (ko) | 방사선 치료 입자 및 현탁액 | |
| CN105012272A (zh) | 一种可用于治疗骨转移癌的氧化还原敏感骨靶向胶束 | |
| JP6836510B2 (ja) | 少なくとも２つの異なるナノ粒子と医薬化合物とを組み合わせた医薬組成物、その調製及び使用 | |
| Groer et al. | Intratumoral cancer chemotherapy with a carrier-based immunogenic cell-death eliciting platinum (IV) Agent | |
| JP2018500298A (ja) | 医薬組成物、その調製及び使用 | |
| JP2025165975A (ja) | 前立腺特異的膜抗原（ｐｓｍａ）リガンド及びその使用 | |
| Song et al. | Dual-targeting nanovesicles enhance specificity to dynamic tumor cells in vitro and in vivo via manipulation of αvβ3-ligand binding | |
| JP6921312B2 (ja) | 薬学的組成物、その製造方法および使用方法 | |
| CN106267238A (zh) | 一种金属富勒烯复合物及其制备方法与应用 | |
| WO2021159547A1 (zh) | 一种预防和/或治疗卵巢癌的多肽药物及其用途 | |
| JP2019512484A (ja) | 骨髄、細網内皮系、および／またはリンパ節を標的にする放射標識リポソームならびにその診断用および治療用使用の方法 | |
| Bao et al. | Applications of biodegradable polymeric nanomaterials as drug delivery systems | |
| Guo et al. | 177Lu-FA-DOTA-PEG-PLGA Nanoparticles Show Antitumor Efficiency in Targeting Ovarian Cancer | |
| Gonzalez et al. | High dose IV Vitamin C and metastatic breast cancer: A case report | |
| Kawak | Ultrasound triggered drug delivery of transferrin coupled liposomes carrying the drug doxorubicin | |
| US11147823B2 (en) | Phospholipid ether analogs for imaging and targeted treatment of pediatric solid tumors | |
| RU2706356C1 (ru) | Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата |